Neogenomics Overview
Neogenomics Target Price
See Neogenomics's analyst price targets ($19) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$17.56
Average Target Price
$19.00
8.2% upside
8.2% upside1 analysts in the last 4 months
High: $19 | Low: $19
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-29 | Craig-Hallum | $19 | 8.2% upside |  |
| 2026-04-29 | Leerink Partners | $25 | 42.4% upside | |
| 2026-02-24 | Piper Sandler | $13 |  26% downside | |
| 2025-10-28 | Leerink Partners | $14 | 20.3% downside | |
| 2025-09-02 | Stephens | $11 | 37.4% downside | |
| 2025-08-04 | Piper Sandler | $11 | 37.4% downside | |
| 2025-07-30 | Morgan Stanley | $8 | 54.4% downside | |
| 2025-07-29 | Needham | $8 | 54.4% downside | |
| 2025-05-06 | Piper SandlerDavid Westenberg | $12 | 31.7% downside | |
| 2025-01-11 | BTIGMark Massaro | $18 | 2.5% upside | |
| 2024-07-30 | NeedhamMike Matson | $19 | 8.2% upside | |
| 2024-05-02 | BTIGMark Massaro | $21 | 19.6% upside | |
| 2023-08-21 | StephensMason Carrico | $18 | 2.5% upside | |
| 2022-08-17 | Piper SandlerDavid Westenberg | $19 | 8.2% upside | |
| 2022-08-10 | Morgan Stanley | $18 | 2.5% upside | |
| 2022-08-10 | Goldman Sachs | $20 | 13.9% upside | |
| 2022-08-10 | Needham | $16 | 8.9% downside | |
| 2022-04-28 | Raymond James | $15 | 14.6% downside | |
| 2021-06-03 | Goldman SachsMatthew Sykes | $55 | 213.2% upside | |
| 2021-05-25 | GuggenheimSandy Draper | $54 | 207.5% upside | |